{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T22:24:53Z","timestamp":1778019893269,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T00:00:00Z","timestamp":1532995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.oret.2018.07.011","type":"journal-article","created":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T00:26:33Z","timestamp":1532478393000},"page":"32-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Ocriplasmin Treatment Leads to Symptomatic Vitreomacular Adhesion\/Vitreomacular Traction Resolution in the Real-World Setting: The Phase IV ORBIT Study"],"prefix":"10.1016","volume":"3","author":[{"given":"Arshad M.","family":"Khanani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay S.","family":"Duker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4625-3145","authenticated-orcid":false,"given":"Jeffrey S.","family":"Heier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter K.","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8781-4370","authenticated-orcid":false,"given":"Brian C.","family":"Joondeph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8678-1693","authenticated-orcid":false,"given":"Petra","family":"Kozma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel F.","family":"Rosberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathew","family":"MacCumber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9936-1652","authenticated-orcid":false,"given":"Dante J.","family":"Pieramici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2018.07.011_bib1","first-page":"224","article-title":"Ocriplasmin for vitreomacular traction","volume":"39","year":"2016","journal-title":"Aust Prescr"},{"issue":"suppl 1","key":"10.1016\/j.oret.2018.07.011_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/eye.2014.125","article-title":"Redesigning services for the management of vitreomacular traction and macular hole","volume":"28","author":"Amoaku","year":"2014","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.oret.2018.07.011_bib3","first-page":"809640","article-title":"A\u00a0review of current management of vitreomacular traction and macular hole","volume":"2015","author":"Garcia-Layana","year":"2015","journal-title":"J\u00a0Ophthalmol"},{"key":"10.1016\/j.oret.2018.07.011_bib4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.17219\/acem\/62122","article-title":"Intravitreal ocriplasmin: a breakthrough in the treatment of vitreomacular traction?","volume":"26","author":"Mec-Slomska","year":"2017","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.oret.2018.07.011_bib5","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1056\/NEJMoa1110823","article-title":"Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes","volume":"367","author":"Stalmans","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"suppl 1","key":"10.1016\/j.oret.2018.07.011_bib6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/eye.2013.212","article-title":"Idiopathic vitreomacular traction and macular hole: a comprehensive review of pathophysiology, diagnosis, and treatment","volume":"27","author":"Steel","year":"2013","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.oret.2018.07.011_bib7","doi-asserted-by":"crossref","unstructured":"Brazier J, Herneib C, Tangelder M, et\u00a0al. Prevalence of metamorphopsia in patients with vitreomacular traction, with or without macular hole and its impact on quality of life: the MeMo study. ISPOR 21st Annual International Meeting. May 21\u201325, 2016, Washington, DC.","DOI":"10.1016\/j.jval.2016.03.516"},{"key":"10.1016\/j.oret.2018.07.011_bib8","doi-asserted-by":"crossref","unstructured":"Patel PJ, Brazier J, Hirneiss C, et\u00a0al, on behalf of the MeMo Study Group. Prevalence of metamorphopsia in patients with vitreomacular traction and its impact on quality of life: the MeMo study. ARVO Annual Meeting. May 1\u20135, 2016, Seattle, Washington.","DOI":"10.1016\/j.jval.2016.03.516"},{"key":"10.1016\/j.oret.2018.07.011_bib9","first-page":"327","article-title":"Predictive factors for the\u00a0spontaneous resolution of vitreomacular traction","volume":"55","author":"Almeida","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2018.07.011_bib10","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00417-016-3294-1","article-title":"A\u00a0retrospective cohort study in patients with tractional diseases of the vitreomacular interface (ReCoVit)","volume":"254","author":"Stalmans","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2018.07.011_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0002-9394(14)73813-9","article-title":"Course of vitreomacular traction syndrome","volume":"119","author":"Hikichi","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2018.07.011_bib12","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1097\/IAE.0000000000001448","article-title":"Pneumatic vitreolysis for relief of vitreomacular traction","volume":"37","author":"Chan","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.oret.2018.07.011_bib13","article-title":"Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole","volume":"4","author":"Bennison","year":"2016","journal-title":"J\u00a0Mark Access Health Policy"},{"key":"10.1016\/j.oret.2018.07.011_bib14","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.ophtha.2016.06.043","article-title":"Results of the 2-Year Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole (OASIS) randomized trial","volume":"123","author":"Dugel","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2018.07.011_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ophtha.2014.07.045","article-title":"Efficacy of intravitreal ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials","volume":"122","author":"Haller","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2018.07.011_bib17","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00417-016-3363-5","article-title":"Ocriplasmin use for vitreomacular traction and macular hole: a meta-analysis and comprehensive review on predictive factors for vitreous release and potential complications","volume":"254","author":"Chatziralli","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2018.07.011_bib18","unstructured":"JETREA (ocriplasmin) Intravitreal Injection, 2.5 mg\/mL. Prescribing Information. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/125422s000lbl.pdf; 2012. Accessed August 9, 2018."},{"key":"10.1016\/j.oret.2018.07.011_bib20","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/bjophthalmol-2013-304219","article-title":"Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndrome","volume":"98","author":"Singh","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2018.07.011_bib21","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/eye.2013.94","article-title":"Correlation of transient vision loss with outer retinal disruption following intravitreal ocriplasmin","volume":"27","author":"Freund","year":"2013","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.oret.2018.07.011_bib22","series-title":"Guide to Interpreting Spectral Domain Optical Coherence Tomography","author":"Lumbroso","year":"2011"},{"key":"10.1016\/j.oret.2018.07.011_bib23","article-title":"Optical coherence tomography in the diagnosis and monitoring of retinal diseases","author":"T\u0103lu","year":"2013","journal-title":"ISRN Biomed Imaging"},{"key":"10.1016\/j.oret.2018.07.011_bib24","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00417-013-2266-y","article-title":"Posterior vitreous detachment following intravitreal drug injection","volume":"251","author":"Geck","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653017306723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653017306723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:25:11Z","timestamp":1762853111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653017306723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S2468653017306723"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2018.07.011","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocriplasmin Treatment Leads to Symptomatic Vitreomacular Adhesion\/Vitreomacular Traction Resolution in the Real-World Setting: The Phase IV ORBIT Study","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2018.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of OphthalmologyThis is an open access article under the CC BY-NC-ND license (<inter-ref xlink: href=http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/>http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/<\/inter-ref>).","name":"copyright","label":"Copyright"}]}}